Market overview
The global capsule endoscope and workstations market is worth USD 562 mn in 2026 and is forecast to reach USD 1.2 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Small-bowel capsules is the largest by product segment.
| Scope | Swallowable camera capsules for the small bowel, colon and stomach with the recorders, sensor arrays and review workstations used to read them. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 520 mn |
| Value 2026 | USD 562 mn |
| Value 2036 | USD 1.2 bn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 670 thousand capsules |
| Volume 2036 | 1,380 thousand capsules |
| Average price 2026 | USD 839 per capsule |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Capsule Endoscope and Workstations market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 562 mn |
| 2027 | USD 604 mn |
| 2028 | USD 649 mn |
| 2029 | USD 698 mn |
| 2030 | USD 750 mn |
| 2031 | USD 806 mn |
| 2032 | USD 867 mn |
| 2033 | USD 932 mn |
| 2034 | USD 1.0 bn |
| 2035 | USD 1.1 bn |
| 2036 | USD 1.2 bn |
Capsule Endoscope and Workstations market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Small-bowel capsules | 52.0% | 43.8% | USD 292 mn | 5.7% |
| Colon capsules | 18.0% | 19.1% | USD 101 mn | 8.1% |
| Magnetically guided capsules | 8.0% | 15.8% | USD 45 mn | 15.1% |
| Workstations and software | 22.0% | 21.3% | USD 124 mn | 7.2% |
By use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Obscure GI bleeding | 44.0% | 39.2% | USD 247 mn | 6.3% |
| Crohn's disease and small-bowel disorders | 30.0% | 30.8% | USD 168 mn | 7.8% |
| Colon screening | 16.0% | 20.6% | USD 90 mn | 10.3% |
| Other | 10.0% | 9.3% | USD 56 mn | 6.8% |
By capsule type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Small bowel capsule | 62.0% | 56.0% | USD 348 mn | 6.4% |
| Colon capsule | 16.0% | 18.0% | USD 90 mn | 8.8% |
| Magnetically controlled gastric | 14.0% | 18.0% | USD 79 mn | 10.2% |
| Esophageal and others | 8.0% | 8.0% | USD 45 mn | 7.5% |
By software
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Image reading workstations | 40.0% | 38.0% | USD 225 mn | 7.0% |
| AI analysis modules | 24.0% | 30.0% | USD 135 mn | 9.9% |
| Cloud viewing | 36.0% | 32.0% | USD 202 mn | 6.2% |
By disease
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Obscure GI bleeding | 38.0% | 34.0% | USD 213 mn | 6.3% |
| Crohn disease | 22.0% | 22.0% | USD 124 mn | 7.5% |
| Gastric disease | 20.0% | 23.0% | USD 112 mn | 9.0% |
| Colorectal screening | 20.0% | 21.0% | USD 112 mn | 8.0% |
Top 25 countries for capsule endoscope and workstations by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 91.0% of 2026 revenue and the 25 countries below together hold 97.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 213 mn | 38.0% | USD 428 mn | 7.2% |
| 2 | Japan | USD 67 mn | 12.0% | USD 123 mn | 6.2% |
| 3 | China | USD 62 mn | 11.0% | USD 163 mn | 10.2% |
| 4 | Germany | USD 45 mn | 8.0% | USD 86 mn | 6.7% |
| 5 | France | USD 28 mn | 5.0% | USD 53 mn | 6.6% |
| 6 | United Kingdom | USD 22 mn | 4.0% | USD 43 mn | 6.7% |
| 7 | Italy | USD 22 mn | 4.0% | USD 43 mn | 6.7% |
| 8 | South Korea | USD 20 mn | 3.5% | USD 42 mn | 7.8% |
| 9 | Spain | USD 17 mn | 3.0% | USD 32 mn | 6.8% |
| 10 | India | USD 14 mn | 2.5% | USD 43 mn | 11.8% |
| 11 | Netherlands | USD 5.8 mn | 1.0% | USD 12 mn | 7.1% |
| 12 | Israel | USD 5.4 mn | 1.0% | USD 11 mn | 7.2% |
| 13 | Australia | USD 4.0 mn | 0.7% | USD 7.9 mn | 7.0% |
| 14 | Canada | USD 3.1 mn | 0.6% | USD 6.2 mn | 7.1% |
| 15 | Belgium | USD 2.8 mn | 0.5% | USD 5.4 mn | 7.0% |
| 16 | Brazil | USD 2.7 mn | 0.5% | USD 6.0 mn | 8.4% |
| 17 | Austria | USD 2.2 mn | 0.4% | USD 4.3 mn | 6.9% |
| 18 | Switzerland | USD 1.7 mn | 0.3% | USD 3.5 mn | 7.2% |
| 19 | Taiwan | USD 1.7 mn | 0.3% | USD 3.8 mn | 8.2% |
| 20 | Saudi Arabia | USD 1.4 mn | 0.2% | USD 3.1 mn | 8.3% |
| 21 | Mexico | USD 1.1 mn | 0.2% | USD 2.4 mn | 8.0% |
| 22 | Sweden | USD 1.1 mn | 0.2% | USD 2.2 mn | 7.5% |
| 23 | Singapore | USD 0.90 mn | 0.2% | USD 2.0 mn | 8.2% |
| 24 | Poland | USD 0.73 mn | 0.1% | USD 1.6 mn | 8.3% |
| 25 | Turkey | USD 0.67 mn | 0.1% | USD 1.5 mn | 8.4% |
| Rest of world | USD 15 mn | 2.7% | USD 30 mn | 6.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Medtronic
- Olympus
- CapsoVision
Group 2: Regional and specialist players
- Jinshan Science and Technology
- IntroMedic
- Fujifilm
- RF System Lab
Group 3: Emerging and niche players
- Ankon Technologies
- Check-Cap
- Medicaltek
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the capsule endoscope and workstations market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by product, by use, by capsule type, by software, by disease. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the capsule endoscope and workstations market?
The global capsule endoscope and workstations market is estimated at USD 520 mn in 2025 and USD 562 mn in 2026.
How fast will the capsule endoscope and workstations market grow?
It is forecast to reach USD 1.2 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 596 mn.
Which country is the largest market for capsule endoscope and workstations?
United States is the largest market by revenue at USD 213 mn in 2026, 38.0% of the global total. The three largest countries together hold 61.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.8% a year from 2026 to 2036.
Which capsule endoscope and workstations segment is largest?
In the by product split, Small-bowel capsules is the largest segment with 52.0% of 2026 revenue.
Who are the leading capsule endoscope and workstations companies?
Global leaders include Medtronic, Olympus, CapsoVision.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Cancer Survivorship NutritionUSD 554 mn · 6.5% CAGR
- Micro Balloon CatheterUSD 554 mn · 6.2% CAGR
- Shelf-Stable Clinical MealUSD 551 mn · 6.5% CAGR
- Widefield Imaging SystemsUSD 551 mn · 6.5% CAGR
- Wound Irrigation SystemsUSD 551 mn · 5.8% CAGR
- Continuous Flow BioreactorsUSD 549 mn · 11.0% CAGR
- Reproductive Toxicity StudiesUSD 549 mn · 5.3% CAGR
- Pharmaceutical Omega-3 APIUSD 546 mn · 5.5% CAGR
← Canine Fungal Infection Treatment Capsule Filling Machine →